Tenaya Therapeutics Valuation
| TNYA Stock | USD 3.58 0.01 0.28% |
At this time, the company appears to be undervalued. Tenaya Therapeutics has a current Real Value of $7.76 per share. The regular price of the company is $3.58. Our model measures the value of Tenaya Therapeutics from inspecting the company fundamentals such as Return On Equity of -0.84, shares owned by institutions of 73.73 %, and Shares Outstanding of 79.22 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Tenaya Therapeutics' valuation include:
Price Book 2.5117 | Enterprise Value 217.9 M | Enterprise Value Ebitda (0.67) |
Undervalued
Today
Please note that Tenaya Therapeutics' price fluctuation is relatively risky at this time. Calculation of the real value of Tenaya Therapeutics is based on 3 months time horizon. Increasing Tenaya Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Tenaya Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tenaya Stock. However, Tenaya Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.58 | Real 7.76 | Target 21.33 | Hype 3.52 | Naive 4.08 |
The real value of Tenaya Stock, also known as its intrinsic value, is the underlying worth of Tenaya Therapeutics Company, which is reflected in its stock price. It is based on Tenaya Therapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Tenaya Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Tenaya Therapeutics helps investors to forecast how Tenaya stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tenaya Therapeutics more accurately as focusing exclusively on Tenaya Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Tenaya Therapeutics' intrinsic value based on its ongoing forecasts of Tenaya Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Tenaya Therapeutics' closest peers. If more than one evaluation category is relevant for Tenaya Therapeutics we suggest using both methods to arrive at a better estimate.
Tenaya Therapeutics Cash |
|
Tenaya Valuation Trend
Comparing Tenaya Therapeutics' enterprise value against its market capitalization is a good way to estimate the value of Tenaya Therapeutics uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Tenaya Therapeutics Total Value Analysis
Tenaya Therapeutics is at this time anticipated to have valuation of 217.89 M with market capitalization of 282.82 M, debt of 12.42 M, and cash on hands of 180.92 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Tenaya Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
217.89 M | 282.82 M | 12.42 M | 180.92 M |
Tenaya Therapeutics Asset Utilization
One of the ways to look at asset utilization of Tenaya is to check how much profit was generated for every dollar of assets it reports. Tenaya Therapeutics has a negative utilization of assets of -0.46 %, losing $0.004594 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Tenaya Therapeutics shows how discouraging it operates for each dollar spent on its assets.Tenaya Therapeutics Ownership Allocation
Tenaya Therapeutics shows a total of 79.22 Million outstanding shares. The majority of Tenaya Therapeutics outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Tenaya Therapeutics to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Tenaya Therapeutics. Please pay attention to any change in the institutional holdings of Tenaya Therapeutics as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Tenaya Therapeutics Profitability Analysis
Net Loss for the year was (124.08 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Tenaya Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Tenaya Therapeutics and how it compares across the competition.
About Tenaya Therapeutics Valuation
The stock valuation mechanism determines Tenaya Therapeutics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Tenaya Therapeutics. We calculate exposure to Tenaya Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tenaya Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -8.7 M | -8.3 M |
Tenaya Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 73.8 M |
Tenaya Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Tenaya Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Tenaya we look at many different elements of the entity such as Tenaya's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Tenaya Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Tenaya Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Tenaya Therapeutics' worth.Complementary Tools for Tenaya Stock analysis
When running Tenaya Therapeutics' price analysis, check to measure Tenaya Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenaya Therapeutics is operating at the current time. Most of Tenaya Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenaya Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenaya Therapeutics' price. Additionally, you may evaluate how the addition of Tenaya Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |